Amarin Corp Plc (AMRN)

[Number sleven]

Jasbg, Some of the people who post on this board are sharing information about the company. Information that is relevant, in order to predict an outcome. Evaluating this company is a complicated endeavor. Start with the product. I think most here agree about the medical value. How does the medical value equate to economic value? Both for the company and product providers. How long does it take for a new cardiovascular product to be excepted by practicing physicians? We need to consider global political and economic factors. This is important when we try to predict potential reimbursement. We also need to follow several legal proceedings. Patent challenge in Europe. We were successful on that. Ongoing litigation in the United States. Are there emerging competitive products. So far nothing that I see as a direct threat. We need to track the company balance sheet and supply chain. These are just some of the issues that investors need to monitor, evaluate, and possibly discuss. The "fact" that you own 62.000 shares and don't like electric cars, isn't actually relevant. I'm bald and have a beard. Those are two facts. Also not relevant.
Sleven,